Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shin Poong PharmCo Ltd (019170) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3488
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostatic hyperplasia drugs, among others. It also provides antibiotics, antifungal and antiviral agents, antiulcerants, anti-diabetics, and trichogens. Shin Poong offers cardiovascular, anti-diabetic, NSAIDs, anti-biotic, propulsive, anti-ulcer, anti-arthritis, anti-spasmodic, respiratory, anti-cancer, and anti-helminthic APIs, among others. The company also provides chemotherapeutics, contraceptive agents, and other products. It has its operations through its production facilities located in Gyeonggi-do and Chungcheongbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.

Shin Poong PharmCo Ltd (019170) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Licensing Agreements 13
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Equity Offering 15
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd – Key Competitors 16
Shin Poong PharmCo Ltd – Key Employees 17
Shin Poong PharmCo Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd, Key Competitors 16
Shin Poong PharmCo Ltd, Key Employees 17
Shin Poong PharmCo Ltd, Other Locations 18
Shin Poong PharmCo Ltd, Subsidiaries 18

List of Figures
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Kyocera Corporation:企業の戦略・SWOT・財務情報
    Kyocera Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyocera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Recipharm AB (RECI B):企業の財務・戦略的SWOT分析
    Recipharm AB (RECI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • United Parcel Service Inc (UPS):企業の財務・戦略的SWOT分析
    United Parcel Service Inc (UPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Verizon Communications Inc (VZ):企業の財務・戦略的SWOT分析
    Verizon Communications Inc (VZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dominion Energy Inc (D):電力:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Paragon Offshore Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Paragon Offshore Plc (Paragon Offshore) is an oil and gas company that offers offshore drilling rigs. The company provides contract drilling, maintenance and fleet management services. It operates through a fleet of rigs including Jackup rigs, Drillships and semi submersible rigs. Paragon Of …
  • Future Fund:企業の戦略的SWOT分析
    Future Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shima Seiki Mfg Ltd (6222):企業の財務・戦略的SWOT分析
    Shima Seiki Mfg Ltd (6222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mapfre S.A. (MAP):企業の財務・戦略的SWOT分析
    Mapfre S.A. (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AgaMatrix Inc-医療機器分野:企業M&A・提携分析
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products include advanced blood glucose monitoring systems, and diabetes data management systems. AgaMatrix uses pr …
  • Epcor Utilities Inc:企業の戦略的SWOT分析
    Epcor Utilities Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Amneal Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Amneal Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amneal Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務分析
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Southwest Gas Holdings, Inc.:企業の戦略・SWOT・財務分析
    Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) operates as a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, …
  • Akonni Biosystems Inc:企業の製品パイプライン分析2018
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆